Comparison · NCT02024867-90f4cb2e
3 Days vs 10 Days: Recurrent Skin Infections Among Patients Infected With Methicillin-Resistant Staphylococcus Aureus
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. 3 Days vs 10 Days: Recurrent Skin Infections Among Patients Infected With Methicillin-Resistant Staphylococcus Aureus. Trial comparisons, record NCT02024867-90f4cb2e. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT02024867-90f4cb2e
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.133 | 0.0691 | 0.242 | wilson | |
| Risk in group 2 | 0.0299 | 0.00822 | 0.102 | wilson | |
| Risk difference, group 1 minus group 2 | 0.103 | 0.00656 | 0.214 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 4.47 | 0.987 | 20.2 | log | |
| Odds ratio, group 1 over group 2 | 5 | 1.02 | 24.6 | log | |
| Number needed to treat, for one more participant with the outcome on 3 Days than on 10 Days | 9.66 | 4.67 | 152 | from the risk difference interval |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | 3 Days | Trimethoprim-Sulfamethoxazole dosed at 10 mg Trimethoprim/kg/day divided twice a day, to a maximum of 640 mg Trimethoprim/day | 8 | 60 | OG000 |
| Group 2 | 10 Days | Trimethoprim-Sulfamethoxazole dosed at 10 mg Trimethoprim/kg/day divided twice a day, to a maximum of 640 mg Trimethoprim/day | 2 | 67 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Recurrent Skin Infections Among Patients Infected With Methicillin-Resistant Staphylococcus Aureus
- Description
Rate of recurrent skin infection among follow-up responders 1 month after enrollment. Patients who were treatment failures were excluded from this analysis since they all received additional medical intervention that could affect the outcome measure.
- Time frame
- 1 month after surgical drainage
- Population
Source ClinicalTrials.gov
Trial
- Title
- Evaluation of 3 Versus 10 Days of Antibiotics in Skin Abscesses After Surgical Drainage
- NCT number
- NCT02024867
- Phases
- NA
- Conditions
- Skin Disease, Bacterial, Abscess
- Interventions
- Trimethoprim-Sulfamethoxazole
- Lead sponsor
- Lucy Holmes, MD
- Results first posted
- 2014-09-15
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT02024867?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT02024867-90f4cb2e